Carter Bankshares, Inc. (CARE) Stock Forecast
Data as of May 10, 2026Financial Services · Current price $26.42 (+0.88%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
CARE vs Sector & Market
| Metric | CARE | Financial Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.51 | 2.41 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +2.2% | +62.4% | +16.4% |
| P/E Ratio | 5.36 | -4.66 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $45M | $45M | $46M | 1 |
| 2026-09-30 | $46M | $47M | $47M | 1 |
| 2026-12-31 | $48M | $48M | $49M | 1 |
| 2027-03-31 | $47M | $48M | $48M | 1 |
| 2027-06-30 | $49M | $49M | $50M | 1 |
| 2027-09-30 | $50M | $51M | $52M | 1 |
| 2027-12-31 | $51M | $52M | $52M | 1 |
| 2028-12-31 | $179M | $180M | $181M | 1 |
| 2029-12-31 | $162M | $163M | $163M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.45 | $0.47 | $0.49 | 2 |
| 2026-09-30 | $0.57 | $0.60 | $0.62 | 2 |
| 2026-12-31 | $0.61 | $0.62 | $0.63 | 1 |
| 2027-03-31 | $0.58 | $0.58 | $0.59 | 1 |
| 2027-06-30 | $0.60 | $0.61 | $0.62 | 1 |
| 2027-09-30 | $0.65 | $0.66 | $0.67 | 1 |
| 2027-12-31 | $0.65 | $0.66 | $0.67 | 1 |
| 2028-12-31 | $2.59 | $2.61 | $2.63 | 1 |
| 2029-12-31 | $3.07 | $3.09 | $3.11 | 1 |
Frequently Asked Questions
What is the analyst consensus for CARE?
The consensus among 1 analysts covering Carter Bankshares, Inc. (CARE) is Buy with an average price target of $22.00.
What is the highest price target for CARE?
The highest analyst price target for CARE is $22.00.
What is the lowest price target for CARE?
The lowest analyst price target for CARE is $22.00.
How many analysts cover CARE?
1 analysts have issued ratings for Carter Bankshares, Inc. in the past 12 months.
Is CARE a buy or sell right now?
Based on 1 analyst ratings, CARE has a consensus rating of Buy (2.00/5) with a +2.2% upside to the consensus target of $22.00.
What are the earnings estimates for CARE?
Analysts estimate CARE will report EPS of $0.47 for the period ending 2026-06-30, with revenue estimated at $45M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.